|
JPS5875614A
(en)
*
|
1981-10-28 |
1983-05-07 |
Matsushita Electric Ind Co Ltd |
Exhaust gas purifying device for incinerator
|
|
DE4312016A1
(en)
*
|
1993-04-13 |
1994-10-20 |
Goedecke Ag |
Stable ketamine solutions
|
|
DE19619665C2
(en)
*
|
1996-05-15 |
2001-03-08 |
Goedecke Ag |
Racemate separation of ketamine
|
|
BRPI0002693B8
(en)
*
|
2000-06-19 |
2021-05-25 |
Cristalia Produtos Quim Farmaceuticos Ltda |
process for obtaining the enantiomers of ketamine and its pharmaceutically acceptable salts
|
|
US7273889B2
(en)
|
2002-09-25 |
2007-09-25 |
Innovative Drug Delivery Systems, Inc. |
NMDA receptor antagonist formulation with reduced neurotoxicity
|
|
US9072662B2
(en)
|
2004-03-29 |
2015-07-07 |
Auris Medical Ag |
Methods for the treatment of tinnitus induced by cochlear excitotoxicity
|
|
US20060063802A1
(en)
|
2004-03-29 |
2006-03-23 |
Matthieu Guitton |
Methods for the treatment of tinnitus induced by cochlear excitotoxicity
|
|
US8268866B2
(en)
|
2004-03-29 |
2012-09-18 |
Matthieu Guitton |
Methods for the treatment of tinnitus induced by cochlear excitotoxicity
|
|
EA017264B1
(en)
|
2005-09-28 |
2012-11-30 |
Аурис Медикаль Аг |
Use of arylcycloalkylamide composition for preparing a medicament for the treatment of inner ear disorder
|
|
US20150044200A1
(en)
|
2011-12-12 |
2015-02-12 |
Otolanum Ag |
Treatment of tinnitus through modulation of chloride co-transporter nkcc1 in the auditory system
|
|
SG11201507347QA
(en)
|
2013-03-15 |
2015-10-29 |
Janssen Pharmaceutica Nv |
Pharmaceutical composition of s-ketamine hydrochloride
|
|
EP3964203A1
(en)
|
2013-09-13 |
2022-03-09 |
National University Corporation Chiba University |
Application of r-ketamine and salt thereof as pharmaceuticals
|
|
US10098854B2
(en)
|
2014-08-13 |
2018-10-16 |
Janssen Pharmaceutica Nv |
Method for the treatment of depression
|
|
EP3725307A1
(en)
|
2014-09-15 |
2020-10-21 |
Janssen Pharmaceutica NV |
Val66met (snp rs6265) genotype specific dosing regimens and methods for the treatment of depression
|
|
US20160332962A1
(en)
*
|
2015-05-13 |
2016-11-17 |
Janssen Pharmaceutica Nv |
(s)-csa salt of s-ketamine, (r)-csa salt of s-ketamine and processes for the preparation of s-ketamine
|
|
US20200009081A1
(en)
|
2017-09-13 |
2020-01-09 |
Janssen Pharmaceutica N.V. |
Delivery Of Esketamine For The Treatment Of Depression
|
|
MX2020006650A
(en)
|
2017-12-22 |
2020-11-06 |
Janssen Pharmaceuticals Inc |
Esketamine for the treatment of depression.
|
|
CN111936127A
(en)
|
2018-02-15 |
2020-11-13 |
国立大学法人千叶大学 |
Agent for preventing or treating inflammatory disease or bone disease, and pharmaceutical composition
|
|
CN110218157B
(en)
*
|
2018-03-01 |
2022-08-23 |
江苏恒瑞医药股份有限公司 |
Preparation method of R-ketamine and its medicinal salt
|
|
WO2019213551A1
(en)
|
2018-05-04 |
2019-11-07 |
Perception Neuroscience, Inc. |
Methods of treating substance abuse
|
|
WO2020003195A1
(en)
|
2018-06-27 |
2020-01-02 |
Clexio Biosciences Ltd. |
Method of treating major depressive disorder
|
|
KR20210074275A
(en)
|
2018-10-05 |
2021-06-21 |
클렉시오 바이오사이언시스 리미티드 |
Dosage regimen of esketamine to treat major depressive disorder
|
|
WO2020070706A1
(en)
|
2018-10-05 |
2020-04-09 |
Clexio Biosciences Ltd. |
Dosage regime of esketamine for treating major depressive disorder
|
|
WO2020070547A1
(en)
|
2018-10-05 |
2020-04-09 |
Clexio Biosciences Ltd. |
Dosage regime of esketamine for treating major depressive disorder
|
|
WO2020075134A1
(en)
|
2018-10-11 |
2020-04-16 |
Clexio Biosciences Ltd. |
Esketamine for use in treating major depressive disorder
|
|
MX2021010683A
(en)
|
2019-03-05 |
2021-12-10 |
Janssen Pharmaceuticals Inc |
Esketamine for the treatment of depression.
|
|
IL293506A
(en)
|
2019-12-30 |
2022-08-01 |
Clexio Biosciences Ltd |
Dosage regime with esketamine for treating major depressive disorder
|
|
WO2021137148A1
(en)
|
2019-12-30 |
2021-07-08 |
Clexio Biosciences Ltd. |
Dosage regime with esketamine for treating neuropsychiatric or neurological conditions
|
|
CN112125816A
(en)
*
|
2020-03-17 |
2020-12-25 |
国药集团工业有限公司 |
Racemization method of ketamine, its derivative or its salt
|